Streetbeat News

Stock Prices

THC

Tenet Healthcare (THC) shares are up following the announcement of a deal to sell three of its hospitals in South Carolina to Novant Health for $2.4 billion in cash.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 5:05 pm

NTES

Over the past 3 months, 5 Wall Street analysts have provided ratings for NetEase (NASDAQ:NTES), with 4 being bullish and 1 somewhat bullish. The average price target is $132.4, representing an implied upside from the current price of $115.97. The average price target has increased by 5.08% over the past month.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 5:00 pm

M

Telsey Advisory Group has maintained its Market Perform rating for Macy's (NYSE:M) and increased its price target from $14.00 to $15.00. Macy's shares are currently trading up 1.58% at $13.54, and the new price target suggests a potential upside of 10.78%. Macy's operates around 550 stores and a variety of e-commerce sites, with women's products making up 61% of its 2022 sales.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 5:00 pm

NSSC

Needham has reaffirmed its Buy rating on NAPCO Security Techs (NASDAQ:NSSC) and increased its price target from $32.00 to $34.00. NAPCO's shares are currently trading at $27.68, and the new price target suggests a potential upside of 22.83%. NAPCO manufactures security products for various applications in commercial, residential, institutional, industrial, and governmental sectors.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 5:00 pm

CAH

JP Morgan has maintained a Neutral rating for Cardinal Health (NYSE:CAH) and increased its price target from $101.00 to $112.00. Cardinal Health's shares are currently trading at $103.30, and the new price target suggests an 8.42% potential upside. Cardinal Health is a major player in the U.S. pharmaceutical wholesale industry, alongside Cencora and McKesson, and also supplies medical-surgical products globally.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 5:00 pm

REGN

Regeneron Pharmaceuticals (NASDAQ:REGN) has delivered an average annual return of 19.06% over the past 5 years, outperforming the market by 7.81% on an annualized basis. A $100 investment in REGN 5 years ago would be worth $237.99 today. The company currently has a market cap of $87.89 billion.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 5:00 pm

WSM

Goldman Sachs has reaffirmed its Sell rating on Williams-Sonoma (NYSE:WSM) but increased its price target from $127.00 to $144.00. Despite the upgrade in the price target, the new target still suggests a potential downside of 16.6% from the current share price of $172.66. Williams-Sonoma is a leader in the home category with various brand extensions and is expanding in B2B and franchise areas.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 5:00 pm

TMO

Thermo Fisher Scientific (NYSE:TMO) has significantly outperformed the market with an average annual return of 19.53% over the past 15 years. An initial investment of $1000 in TMO 15 years ago would be worth $15,674.74 today. The company's current market capitalization stands at $180.05 billion.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 5:00 pm

CSIQ

UBS has maintained its Buy rating for Canadian Solar (NASDAQ:CSIQ) but reduced its price target from $47.00 to $36.00. Despite the lowered target, the new price suggests a significant upside of 72.74% from the current trading price of $20.84. Canadian Solar operates in the solar power industry, providing products and services across two segments: CSI Solar and Global Energy.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 5:00 pm

USO

Oil prices are facing their fourth consecutive weekly loss, with the market shifting to contango, indicating higher future prices. The December oil futures contract is trading at a discount to April 2024, reflecting current oversupply. The bear market has seen a 21% drop in prices since September 2023. The United States Oil Fund (USO) remains flat YTD. OPEC's upcoming meeting on Nov. 26 will address falling prices and global growth concerns. Goldman Sachs predicts a tighter oil market in 2024, with Brent prices likely maintained between $80-$100 by OPEC.

Portfolio Pulse from Piero Cingari

November 17, 2023 | 4:59 pm